PROTHENA CORPORATION PLC - ORDINARY SHARES

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

18 Jun 2024 13:05:51 By NetDania Notify

NetDania - New 12 months Low: PROTHENA CORPORATION PLC - ORDINARY SHARES

29 May 2024 08:45:04 By NetDania Notify

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

27 Oct 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena to Participate in Upcoming Healthcare Conferences

01 Sep 2022 15:20:00 By Nasdaq GlobeNewswire

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

01 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

08 Aug 2022 15:05:02 By Nasdaq GlobeNewswire

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena to Report Second Quarter 2022 Financial Results on August 8th

01 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Jul 2022 15:16:52 By Nasdaq GlobeNewswire

Prothena to Participate in Jefferies Healthcare Conference

02 Jun 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Reports First Quarter 2022 Financial Results and Business Highlights

05 May 2022 15:05:05 By Nasdaq GlobeNewswire

Prothena to Report First Quarter 2022 Financial Results on May 5th

28 Apr 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease

26 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease

28 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Prothena to Participate in Stifel 2022 Virtual CNS Days

21 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022

16 Mar 2022 04:30:00 By Nasdaq GlobeNewswire

Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights

17 Feb 2022 15:05:01 By Nasdaq GlobeNewswire

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022

10 Feb 2022 15:05:00 By Nasdaq GlobeNewswire

Prothena to Participate in JMP Securities Hematology and Oncology Summit

29 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

04 Nov 2021 15:05:02 By Nasdaq GlobeNewswire